Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Gore

Showing results (121-130 of 138) with videos related to

Pageof 14
Sort By:
Cancer Cell|March 27, 2018
Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 AntibodiesFrederick Arce Vargas, Andrew J S Furness, Kevin Litchfield, et al.
Genome Biology|August 28, 2014
Development of synchronous VHL syndrome tumors reveals contingencies and constraints to tumor evolutionRosalie Fisher, Stuart Horswell, Andrew Rowan, et al.
Journal for Immunotherapy of Cancer|April 23, 2020
Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanomaJonathan S Cebon, Martin Gore, John F Thompson, et al.
Nature Communications|March 20, 2015
Recurrent chromosomal gains and heterogeneous driver mutations characterise papillary renal cancer evolutionMichal Kovac, Carolina Navas, Stuart Horswell, et al.
Cancer Research|May 20, 2016
The BRCA1-Δ11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and CisplatinYifan Wang, Andrea J Bernhardy, Cristina Cruz, et al.
Cell|April 17, 2018
Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx RenalSamra Turajlic, Hang Xu, Kevin Litchfield, et al.
Cell|April 17, 2018
Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx RenalThomas J Mitchell, Samra Turajlic, Andrew Rowan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 17, 2018
Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trialP G Corrie, A Marshall, P D Nathan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2014
Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancerFrancisco J Candido-dos-Reis, Honglin Song, Ellen L Goode, et al.
Nature|December 18, 2012
Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancerElise Ruark, Katie Snape, Peter Humburg, et al.
Pageof 14

Showing results (121-130 of 138) with videos related to

Sort By:
Pageof 14
Cancer Cell|March 27, 2018
Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 AntibodiesFrederick Arce Vargas, Andrew J S Furness, Kevin Litchfield, et al.
Genome Biology|August 28, 2014
Development of synchronous VHL syndrome tumors reveals contingencies and constraints to tumor evolutionRosalie Fisher, Stuart Horswell, Andrew Rowan, et al.
Journal for Immunotherapy of Cancer|April 23, 2020
Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanomaJonathan S Cebon, Martin Gore, John F Thompson, et al.
Nature Communications|March 20, 2015
Recurrent chromosomal gains and heterogeneous driver mutations characterise papillary renal cancer evolutionMichal Kovac, Carolina Navas, Stuart Horswell, et al.
Cancer Research|May 20, 2016
The BRCA1-Δ11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and CisplatinYifan Wang, Andrea J Bernhardy, Cristina Cruz, et al.
Cell|April 17, 2018
Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx RenalSamra Turajlic, Hang Xu, Kevin Litchfield, et al.
Cell|April 17, 2018
Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx RenalThomas J Mitchell, Samra Turajlic, Andrew Rowan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 17, 2018
Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trialP G Corrie, A Marshall, P D Nathan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2014
Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancerFrancisco J Candido-dos-Reis, Honglin Song, Ellen L Goode, et al.
Nature|December 18, 2012
Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancerElise Ruark, Katie Snape, Peter Humburg, et al.
Pageof 14